Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Exercise of Options

18 Dec 2024 15:58

RNS Number : 6390Q
Spectra Systems Corporation
18 December 2024
 

Spectra Systems Corporation

(the "Company")

Exercise of Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, announces the exercise of options by an employee of Spectra.

The employee has exercised options over 13,339 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of 25p per share on 16 December 2024. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 1,339 shares to the Company. Accordingly, the employee will be issued 12,000 shares.

The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly, the Company has issued and will apply for 12,000 Shares to be admitted to trading on AIM, which is expected to take place on or around 24 December 2024 ("Admission").The Company's issued share capital now comprises:

571,380 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

47,669,592 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Spectra Systems has no Shares in treasury, therefore 48,240,972 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus (Nominated Adviser and Broker)

Chris Fielding (Director, Investment Banking)

James Bavister (Assistant Director)

Andrew de Andrade (Associate, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 5000

 

 

 

Tel: +44 (0)20 3328 5665

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFEEFELTLIS
Date   Source Headline
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
2nd Oct 20137:00 amRNSAcquisition of Assets from InkSure Technologies
1st Oct 20137:00 amRNSResult of AGM
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
30th Jul 20137:00 amRNSLarge Order from Central Bank
28th Jun 20137:00 amRNSPosting of Annual Report
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM
30th Apr 20097:51 amRNSNet Asset Value(s)
29th Apr 20097:41 amRNSNet Asset Value(s)
28th Apr 20097:48 amRNSNet Asset Value(s)
27th Apr 20098:04 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.